|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI
|
|
2
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
4
|
Morgan E, Arnold M, Camargo MC, Gini A,
Kunzmann AT, Matsuda T, Meheus F, Verhoeven RHA, Vignat J,
Laversanne M, et al: The current and future incidence and mortality
of gastric cancer in 185 countries, 2020-40: A population-based
modelling study. EClinicalMedicine. 47:1014042022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Correa P, Haenszel W, Cuello C, Tannenbaum
S and Archer M: A model for gastric cancer epidemiology. Lancet.
2:58–60. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yan L, Li W, Chen F, Wang J, Chen J, Chen
Y and Ye W: Inflammation as a mediator of microbiome
Dysbiosis-associated DNA methylation changes in gastric
premalignant lesions. Phenomics. 3:496–501. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang N, He HW, He YY, Gu W, Xu MJ and Liu
L: Xiaotan Sanjie recipe, a compound Chinese herbal medicine,
inhibits gastric cancer metastasis by regulating GnT-V-mediated
E-cadherin glycosylation. J Integr Med. 21:561–574. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Giroux V and Rustgi AK: Metaplasia: Tissue
injury adaptation and a precursor to the dysplasia-cancer sequence.
Nat Rev Cancer. 17:594–604. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Petersen CP, Mills JC and Goldenring JR:
Murine models of gastric corpus preneoplasia. Cell Mol
Gastroenterol Hepatol. 3:11–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang M, Hu S, Min M, Ni Y, Lu Z, Sun X,
Wu J, Liu B, Ying X and Liu Y: Dissecting transcriptional
heterogeneity in primary gastric adenocarcinoma by single cell RNA
sequencing. Gut. 70:464–475. 2021. View Article : Google Scholar
|
|
11
|
Muthupalani S, Ge Z, Joy J, Feng Y, Dobey
C, Cho HY, Langenbach R, Wang TC, Hagen SJ and Fox JG: Muc5ac null
mice are predisposed to spontaneous gastric antro-pyloric
hyperplasia and adenomas coupled with attenuated H. pylori-induced
corpus mucous metaplasia. Lab Invest. 99:1887–1905. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goldenring JR: Spasmolytic
polypeptide-expressing metaplasia (SPEM) cell lineages can be an
origin of gastric cancer. J Pathol. 260:109–111. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt PH, Lee JR, Joshi V, Playford RJ,
Poulsom R, Wright NA and Goldenring JR: Identification of a
metaplastic cell lineage associated with human gastric
adenocarcinoma. Lab Invest. 79:639–646. 1999.PubMed/NCBI
|
|
14
|
Halldórsdóttir AM, Sigurdardóttrir M,
Jónasson JG, Oddsdóttir M, Magnússon J, Lee JR and Goldenring JR:
Spasmolytic polypeptide-expressing metaplasia (SPEM) associated
with gastric cancer in Iceland. Dig Dis Sci. 48:431–441. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamaguchi H, Goldenring JR, Kaminishi M
and Lee JR: Identification of spasmolytic polypeptide expressing
metaplasia (SPEM) in remnant gastric cancer and surveillance
postgastrectomy biopsies. Dig Dis Sci. 47:573–578. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Katz JP, Perreault N, Goldstein BG, Actman
L, McNally SR, Silberg DG, Furth EE and Kaestner KH: Loss of Klf4
in mice causes altered proliferation and differentiation and
precancerous changes in the adult stomach. Gastroenterology.
128:935–945. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oshima H, Matsunaga A, Fujimura T,
Tsukamoto T, Taketo MM and Oshima M: Carcinogenesis in mouse
stomach by simultaneous activation of the Wnt signaling and
prostaglandin E2 pathway. Gastroenterology. 131:1086–1095. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goldenring JR, Nam KT, Wang TC, Mills JC
and Wright NA: Spasmolytic polypeptide-expressing metaplasia and
intestinal metaplasia: Time for reevaluation of metaplasias and the
origins of gastric cancer. Gastroenterology. 138:2207–2210.e1.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reyes ME, Pulgar V, Vivallo C, Ili CG,
Mora-Lagos B and Brebi P: Epigenetic modulation of cytokine
expression in gastric cancer: Influence on angiogenesis, metastasis
and chemoresistance. Front Immunol. 15:13475302024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bockerstett KA and DiPaolo RJ: Regulation
of gastric carcinogenesis by inflammatory cytokines. Cell Mol
Gastroenterol Hepatol. 4:47–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Briukhovetska D, Dörr J, Endres S, Libby
P, Dinarello CA and Kobold S: Interleukins in cancer: From biology
to therapy. Nat Rev Cancer. 21:481–499. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dranoff G: Cytokines in cancer
pathogenesis and cancer therapy. Nat Rev Cancer. 4:11–22. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yasmin R, Siraj S, Hassan A, Khan AR,
Abbasi R and Ahmad N: Epigenetic regulation of inflammatory
cytokines and associated genes in human malignancies. Mediators
Inflamm. 2015:2017032015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oshima M, Oshima H, Matsunaga A and Taketo
MM: Hyperplastic gastric tumors with spasmolytic
polypeptide-expressing metaplasia caused by tumor necrosis
factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal
prostaglandin E synthase-1 transgenic mice. Cancer Res.
65:9147–9151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee C, Lee H, Hwang SY, Moon CM and Hong
SN: IL-10 plays a pivotal role in Tamoxifen-induced spasmolytic
Polypeptide-expressing metaplasia in gastric mucosa. Gut Liver.
11:789–797. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Demitrack ES, Gifford GB, Keeley TM,
Horita N, Todisco A, Turgeon DK, Siebel CW and Samuelson LC: NOTCH1
and NOTCH2 regulate epithelial cell proliferation in mouse and
human gastric corpus. Am J Physiol Gastrointest Liver Physiol.
312:G133–G144. 2017. View Article : Google Scholar :
|
|
27
|
Negovan A, Iancu M, Fülöp E and Bănescu C:
Helicobacter pylori and cytokine gene variants as predictors of
premalignant gastric lesions. World J Gastroenterol. 25:4105–4124.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zeng X, Yang M, Ye T, Feng J, Xu X, Yang
H, Wang X, Bao L, Li R, Xue B, et al: Mitochondrial GRIM-19 loss in
parietal cells promotes spasmolytic polypeptide-expressing
metaplasia through NLR family pyrin domain-containing 3
(NLRP3)-mediated IL-33 activation via a reactive oxygen species
(ROS)-NRF2-Heme oxygenase-1(HO-1)-NF-кB axis. Free Radic Biol Med.
202:46–61. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Berraondo P, Sanmamed MF, Ochoa MC,
Etxeberria I, Aznar MA, Pérez-Gracia JL, Rodríguez-Ruiz ME,
Ponz-Sarvise M, Castañón E and Melero I: Cytokines in clinical
cancer immunotherapy. Br J Cancer. 120:6–15. 2019. View Article : Google Scholar :
|
|
30
|
Kureshi CT and Dougan SK: Cytokines in
cancer. Cancer Cell. 43:15–35. 2025. View Article : Google Scholar :
|
|
31
|
El-Zaatari M, Kao JY, Tessier A, Bai L,
Hayes MM, Fontaine C, Eaton KA and Merchant JL: Gli1 deletion
prevents Helicobacter-induced gastric metaplasia and expansion of
myeloid cell subsets. PLoS One. 8:e589352013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Goldenring JR, Nam KT and Mills JC: The
origin of pre-neoplastic metaplasia in the stomach: Chief cells
emerge from the Mist. Exp Cell Res. 317:2759–2764. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kang WQ, Rathinavelu S, Samuelson LC and
Merchant JL: Interferon gamma induction of gastric mucous neck cell
hypertrophy. Lab Invest. 85:702–715. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bockerstett KA, Osaki LH, Petersen CP, Cai
CW, Wong CF, Nguyen TM, Ford EL, Hoft DF, Mills JC, Goldenring JR
and DiPaolo RJ: Interleukin-17A promotes parietal cell atrophy by
inducing apoptosis. Cell Mol Gastroenterol Hepatol. 5:678–690.e1.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Caldwell B, Meyer AR, Weis JA, Engevik AC
and Choi E: Chief cell plasticity is the origin of metaplasia
following acute injury in the stomach mucosa. Gut. 71:1068–1077.
2022. View Article : Google Scholar
|
|
36
|
Meyer AR, Engevik AC, Madorsky T, Belmont
E, Stier MT, Norlander AE, Pilkinton MA, McDonnell WJ, Weis JA,
Jang B, et al: Group 2 innate lymphoid cells coordinate damage
response in the stomach. Gastroenterology. 159:2077–2091.e8. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He L, Zhang X, Zhang S, Wang Y, Hu W, Li
J, Liu Y, Liao Y, Peng X, Li J, et al: H. pylori-facilitated
TERT/Wnt/β-Catenin triggers spasmolytic Polypeptide-expressing
metaplasia and oxyntic atrophy. Adv Sci (Weinh). 12:e24012272025.
View Article : Google Scholar
|
|
38
|
Busada JT, Peterson KN, Khadka S, Xu X,
Oakley RH, Cook DN and Cidlowski JA: Glucocorticoids and androgens
protect from gastric metaplasia by suppressing group 2 innate
lymphoid cell activation. Gastroenterology. 161:637–652.e4. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Contreras-Panta EW, Lee SH, Won Y,
Norlander AE, Simmons AJ, Peebles RS Jr, Lau KS, Choi E and
Goldenring JR: Interleukin 13 promotes maturation and proliferation
in metaplastic gastroids. Cell Mol Gastroenterol Hepatol.
18:1013662024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Goldenring JR and Nomura S:
Differentiation of the gastric mucosa III. Animal models of oxyntic
atrophy and metaplasia. Am J Physiol Gastrointest Liver Physiol.
291:G999–G1004. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee SH, Jang B, Min J, Contreras-Panta EW,
Presentation KS, Delgado AG, Piazuelo MB, Choi E and Goldenring JR:
Up-regulation of aquaporin 5 defines spasmolytic
Polypeptide-expressing metaplasia and progression to incomplete
intestinal metaplasia. Cell Mol Gastroenterol Hepatol. 13:199–217.
2022. View Article : Google Scholar
|
|
42
|
Park DJ and Kim SE: The Role of IL-10 in
gastric spasmolytic Polypeptide-expressing Metaplasia-related
carcinogenesis. Gut Liver. 11:741–742. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bockerstett KA, Petersen CP, Noto CN,
Kuehm LM, Wong CF, Ford EL, Teague RM, Mills JC, Goldenring JR and
DiPaolo RJ: Interleukin 27 protects from gastric atrophy and
metaplasia during chronic autoimmune gastritis. Cell Mol
Gastroenterol Hepatol. 10:561–579. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
de Brito BB, da Silva FAF and de Melo FF:
Role of polymorphisms in genes that encode cytokines and
Helicobacter pylori virulence factors in gastric carcinogenesis.
World J Clin Oncol. 9:83–89. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Saleh RO, Jasim SA, Kadhum WR, Hjazi A,
Faraz A, Abid MK, Yumashev A, Alawadi A, Aiad IAZ and Alsalamy A:
Exploring the detailed role of interleukins in cancer: A
comprehensive review of literature. Pathol Res Pract.
257:1552842024. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Propper DJ and Balkwill FR: Harnessing
cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol.
19:237–253. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lamkanfi M and Dixit VM: Mechanisms and
functions of inflammasomes. Cell. 157:1013–1022. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Santos JC, Ladeira MS, Pedrazzoli J Jr and
Ribeiro ML: Relationship of IL-1 and TNF-α polymorphisms with
Helicobacter pylori in gastric diseases in a Brazilian population.
Braz J Med Biol Res. 45:811–817. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Starzyńska T, Ferenc K, Wex T, Kähne T,
Lubiński J, Lawniczak M, Marlicz K and Malfertheiner P: The
association between the interleukin-1 polymorphisms and gastric
cancer risk depends on the family history of gastric carcinoma in
the study population. Am J Gastroenterol. 101:248–254. 2006.
View Article : Google Scholar
|
|
50
|
Xue H, Lin B, Ni P, Xu H and Huang G:
Interleukin-1B and interleukin-1 RN polymorphisms and gastric
carcinoma risk: A meta-analysis. J Gastroenterol Hepatol.
25:1604–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang YM, Li ZX, Tang FB, Zhang Y, Zhou T,
Zhang L, Ma JL, You WC and Pan KF: Association of genetic
polymorphisms of interleukins with gastric cancer and precancerous
gastric lesions in a high-risk Chinese population. Tumour Biol.
37:2233–2242. 2016. View Article : Google Scholar
|
|
52
|
Myung DS, Lee WS, Park YL, Kim N, Oh HH,
Kim MY, Oak CY, Chung CY, Park HC, Kim JS, et al: Association
between interleukin-18 gene polymorphism and Helicobacter pylori
infection in the Korean population. Sci Rep. 5:115352015.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cheung H, Chen NJ, Cao Z, Ono N, Ohashi PS
and Yeh WC: Accessory protein-like is essential for IL-18-mediated
signaling. J Immunol. 174:5351–5357. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Osaki LH, Bockerstett KA, Wong CF, Ford
EL, Madison BB, DiPaolo RJ and Mills JC: Interferon-γ directly
induces gastric epithelial cell death and is required for
progression to metaplasia. J Pathol. 247:513–523. 2019. View Article : Google Scholar :
|
|
55
|
Syu LJ, El-Zaatari M, Eaton KA, Liu Z,
Tetarbe M, Keeley TM, Pero J, Ferris J, Wilbert D, Kaatz A, et al:
Transgenic expression of interferon-γ in mouse stomach leads to
inflammation, metaplasia, and dysplasia. Am J Pathol.
181:2114–2125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Leung WK, Chan MC, To KF, Man EP, Ng EK,
Chu ES, Lau JY, Lin SR and Sung JJ: H. pylori genotypes and
cytokine gene polymorphisms influence the development of gastric
intestinal metaplasia in a Chinese population. Am J Gastroenterol.
101:714–720. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
He R, Yin H, Yuan B, Liu T, Luo L, Huang
P, Dai L and Zeng K: IL-33 improves wound healing through enhanced
M2 macrophage polarization in diabetic mice. Mol Immunol. 90:42–49.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Schmitz J, Owyang A, Oldham E, Song Y,
Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, et
al: IL-33, an interleukin-1-like cytokine that signals via the IL-1
receptor-related protein ST2 and induces T helper type 2-associated
cytokines. Immunity. 23:479–490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Carriere V, Roussel L, Ortega N, Lacorre
DA, Americh L, Aguilar L, Bouche G and Girard JP: IL-33, the
IL-1-like cytokine ligand for ST2 receptor, is a
chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci
USA. 104:282–287. 2007. View Article : Google Scholar :
|
|
60
|
Buzzelli JN, Chalinor HV, Pavlic DI,
Sutton P, Menheniott TR, Giraud AS and Judd LM: IL33 is a stomach
alarmin that initiates a skewed Th2 response to injury and
infection. Cell Mol Gastroenterol Hepatol. 1:203–221.e3. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Schwartz C, O'Grady K, Lavelle EC and
Fallon PG: Interleukin 33: An innate alarm for adaptive responses
beyond Th2 immunity-emerging roles in obesity, intestinal
inflammation, and cancer. Eur J Immunol. 46:1091–1100. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
De Salvo C, Pastorelli L, Petersen CP,
Buttò LF, Buela KA, Omenetti S, Locovei SA, Ray S, Friedman HR,
Duijser J, et al: Interleukin 33 triggers early
Eosinophil-dependent events leading to metaplasia in a chronic
model of Gastritis-prone mice. Gastroenterology. 160:302–316.e7.
2021. View Article : Google Scholar
|
|
63
|
Petersen CP, Meyer AR, De Salvo C, Choi E,
Schlegel C, Petersen A, Engevik AC, Prasad N, Levy SE, Peebles RS,
et al: A signalling cascade of IL-33 to IL-13 regulates metaplasia
in the mouse stomach. Gut. 67:805–817. 2018. View Article : Google Scholar
|
|
64
|
Huang N, Cui X, Li W, Zhang C, Liu L and
Li J: IL-33/ST2 promotes the malignant progression of gastric
cancer via the MAPK pathway. Mol Med Rep. 23:3612021. View Article : Google Scholar :
|
|
65
|
Engevik AC, Feng R, Choi E, White S,
Bertaux-Skeirik N, Li J, Mahe MM, Aihara E, Yang L, DiPasquale B,
et al: The development of spasmolytic polypeptide/TFF2-expressing
metaplasia (SPEM) during gastric repair is absent in the aged
stomach. Cell Mol Gastroenterol Hepatol. 2:605–624. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Farrell JJ, Taupin D, Koh TJ, Chen D, Zhao
CM, Podolsky DK and Wang TC: TFF2/SP-deficient mice show decreased
gastric proliferation, increased acid secretion, and increased
susceptibility to NSAID injury. J Clin Invest. 109:193–204. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Nozaki K, Ogawa M, Williams JA, Lafleur
BJ, Ng V, Drapkin RI, Mills JC, Konieczny SF, Nomura S and
Goldenring JR: A molecular signature of gastric metaplasia arising
in response to acute parietal cell loss. Gastroenterology.
134:511–522. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Privitera G, Williams JJ and De Salvo C:
The importance of Th2 immune responses in mediating the progression
of Gastritis-associated metaplasia to gastric cancer. Cancers
(Basel). 16:5222024. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Meyer AR and Goldenring JR: Injury,
repair, inflammation and metaplasia in the stomach. J Physiol.
596:3861–3867. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Gordon S: Alternative activation of
macrophages. Nat Rev Immunol. 3:23–35. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Bernink JH, Germar K and Spits H: The role
of ILC2 in pathology of type 2 inflammatory diseases. Curr Opin
Immunol. 31:115–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Li W, Huang X, Han X, Zhang J, Gao L and
Chen H: IL-17A in gastric carcinogenesis: Good or bad? Front
Immunol. 15:15012932024. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Pisani LF, Teani I, Vecchi M and
Pastorelli L: Interleukin-33: Friend or foe in gastrointestinal
tract cancers? Cells. 12:14812023. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ye Q, Zhu Y, Ma Y, Wang Z and Xu G:
Emerging role of spasmolytic polypeptide-expressing metaplasia in
gastric cancer. J Gastrointest Oncol. 15:2673–2683. 2024.
View Article : Google Scholar
|
|
75
|
Melchiades JL, Zabaglia LM, Sallas ML,
Orcini WA, Chen E, Smith MAC, Payão SLM and Rasmussen LT:
Polymorphisms and haplotypes of the interleukin 2 gene are
associated with an increased risk of gastric cancer. The possible
involvement of Helicobacter pylori. Cytokine. 96:203–207. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Shin WG, Jang JS, Kim HS, Kim SJ, Kim KH,
Jang MK, Lee JH, Kim HJ and Kim HY: Polymorphisms of interleukin-1
and interleukin-2 genes in patients with gastric cancer in Korea. J
Gastroenterol Hepatol. 23:1567–1573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Mohammadi M, Czinn S, Redline R and Nedrud
J: Helicobacter-specific cell-mediated immune responses display a
predominant Th1 phenotype and promote a delayed-type
hypersensitivity response in the stomachs of mice. J Immunol.
156:4729–4738. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Roth KA, Kapadia SB, Martin SM and Lorenz
RG: Cellular immune responses are essential for the development of
Helicobacter felis-associated gastric pathology. J Immunol.
163:1490–1497. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Yang E, Chua W, Ng W and Roberts TL:
Peripheral cytokine levels as a prognostic indicator in gastric
cancer: A review of existing literature. Biomedicines. 9:19162021.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Bevington SL, Keane P, Soley JK, Tauch S,
Gajdasik DW, Fiancette R, Matei-Rascu V, Willis CM, Withers DR and
Cockerill PN: IL-2/IL-7-inducible factors pioneer the path to T
cell differentiation in advance of lineage-defining factors. EMBO
J. 39:e1052202020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Bamford KB, Fan X, Crowe SE, Leary JF,
Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE and Ernst PB:
Lymphocytes in the human gastric mucosa during Helicobacter pylori
have a T helper cell 1 phenotype. Gastroenterology. 114:482–492.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Padol IT and Hunt RH: Effect of Th1
cytokines on acid secretion in pharmacologically characterised
mouse gastric glands. Gut. 53:1075–1081. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Togawa S, Joh T, Itoh M, Katsuda N, Ito H,
Matsuo K, Tajima K and Hamajima N: Interleukin-2 gene polymorphisms
associated with increased risk of gastric atrophy from Helicobacter
pylori infection. Helicobacter. 10:172–178. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Van Dyken SJ and Locksley RM:
Interleukin-4- and interleukin-13-mediated alternatively activated
macrophages: Roles in homeostasis and disease. Annu Rev Immunol.
31:317–343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Pan K, Li Q, Guo Z and Li Z: Healing
action of Interleukin-4 (IL-4) in acute and chronic inflammatory
conditions: Mechanisms and therapeutic strategies. Pharmacol Ther.
265:1087602025. View Article : Google Scholar
|
|
86
|
Labonte AC, Tosello-Trampont AC and Hahn
YS: The role of macrophage polarization in infectious and
inflammatory diseases. Mol Cells. 37:275–285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Liu YC, Zou XB, Chai YF and Yao YM:
Macrophage polarization in inflammatory diseases. Int J Biol Sci.
10:520–529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Petersen CP, Weis VG, Nam KT, Sousa JF,
Fingleton B and Goldenring JR: Macrophages promote progression of
spasmolytic polypeptide-expressing metaplasia after acute loss of
parietal cells. Gastroenterology. 146:1727–1738.e8. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Yoshimoto T: The hunt for the source of
primary Interleukin-4: How we discovered that natural killer T
cells and basophils determine T helper type 2 cell differentiation
in vivo. Front Immunol. 9:7162018. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhou JY, Alvarez CA and Cobb BA:
Integration of IL-2 and IL-4 signals coordinates divergent
regulatory T cell responses and drives therapeutic efficacy. Elife.
10:e574172021. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhang Z, Chen Z, Que Z, Fang Z, Zhu H and
Tian J: Chinese medicines and natural medicine as immunotherapeutic
agents for gastric cancer: Recent advances. Cancer Rep (Hoboken).
7:e21342024.
|
|
92
|
Yang F, Shaibu Z, Liu Q and Zhu W:
Cytokine profiles as predictive biomarkers for treatment outcomes
in advanced gastric cancer patients undergoing PD-1 blockade
immunochemotherapy: A meta-analysis. Clin Exp Med. 25:1362025.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Ham IH, Oh HJ, Jin H, Bae CA, Jeon SM,
Choi KS, Son SY, Han SU, Brekken RA, Lee D and Hur H: Targeting
interleukin-6 as a strategy to overcome Stroma-induced resistance
to chemotherapy in gastric cancer. Mol Cancer. 18:682019.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Wu X, Tao P, Zhou Q, Li J, Yu Z, Wang X,
Li J, Li C, Yan M, Zhu Z, et al: IL-6 secreted by cancer-associated
fibroblasts promotes epithelial-mesenchymal transition and
metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Oncotarget. 8:20741–20750. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Matsuo K, Oka M, Murase K, Soda H, Isomoto
H, Takeshima F, Mizuta Y, Murata I and Kohno S: Expression of
interleukin 6 and its receptor in human gastric and colorectal
cancers. J Int Med Res. 31:69–75. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Leja M, Wex T and Malfertheiner P: Markers
for gastric cancer premalignant lesions: Where do we go? Dig Dis.
30:268–276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Johnson DE, O'Keefe RA and Grandis JR:
Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev
Clin Oncol. 15:234–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Giraud AS, Jackson C, Menheniott TR and
Judd LM: Differentiation of the gastric mucosa IV. Role of trefoil
peptides and IL-6 cytokine family signaling in gastric homeostasis.
Am J Physiol Gastrointest Liver Physiol. 292:G1–G5. 2007.
View Article : Google Scholar
|
|
99
|
Kamimura D, Ishihara K and Hirano T: IL-6
signal transduction and its physiological roles: The signal
orchestration model. Rev Physiol Biochem Pharmacol. 149:1–38.
2003.PubMed/NCBI
|
|
100
|
Lee IO, Kim JH, Choi YJ, Pillinger MH, Kim
SY, Blaser MJ and Lee YC: Helicobacter pylori CagA phosphorylation
status determines the gp130-activated SHP2/ERK and JAK/STAT signal
transduction pathways in gastric epithelial cells. J Biol Chem.
285:16042–16050. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Judd LM, Menheniott TR, Ling H, Jackson
CB, Howlett M, Kalantzis A, Priebe W and Giraud AS: Inhibition of
the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and
in vivo. PLoS One. 9:e959932014. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Hwang IR, Hsu PI, Peterson LE, Gutierrez
O, Kim JG, Graham DY and Yamaoka Y: Interleukin-6 genetic
polymorphisms are not related to Helicobacter pylori-associated
gastroduodenal diseases. Helicobacter. 8:142–148. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Howlett M, Chalinor HV, Buzzelli JN,
Nguyen N, van Driel IR, Bell KM, Fox JG, Dimitriadis E, Menheniott
TR, Giraud AS and Judd LM: IL-11 is a parietal cell cytokine that
induces atrophic gastritis. Gut. 61:1398–1409. 2012. View Article : Google Scholar
|
|
104
|
Buzzelli JN, O'Connor L, Scurr M, Chung
Nien Chin S, Catubig A, Ng GZ, Oshima M, Oshima H, Giraud AS,
Sutton P, et al: Overexpression of IL-11 promotes premalignant
gastric epithelial hyperplasia in isolation from germline
gp130-JAK-STAT driver mutations. Am J Physiol Gastrointest Liver
Physiol. 316:G251–G262. 2019. View Article : Google Scholar
|
|
105
|
Howlett M, Giraud AS, Lescesen H, Jackson
CB, Kalantzis A, Van Driel IR, Robb L, Van der Hoek M, Ernst M,
Minamoto T, et al: The interleukin-6 family cytokine interleukin-11
regulates homeostatic epithelial cell turnover and promotes gastric
tumor development. Gastroenterology. 136:967–977. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Tebbutt NC, Giraud AS, Inglese M, Jenkins
B, Waring P, Clay FJ, Malki S, Alderman BM, Grail D, Hollande F, et
al: Reciprocal regulation of gastrointestinal homeostasis by SHP2
and STAT-mediated trefoil gene activation in gp130 mutant mice.
Nature medicine. 8:1089–1097. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
107
|
Pastorelli L, Garg RR, Hoang SB, Spina L,
Mattioli B, Scarpa M, Fiocchi C, Vecchi M and Pizarro TT:
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in
ulcerative colitis and in experimental Th1/Th2 driven enteritis.
Proc Natl Acad Sci USA. 107:8017–8022. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Saha A, Hammond CE, Gooz M and Smolka AJ:
The role of Sp1 in IL-1beta and H. pylori-mediated regulation of
H,K-ATPase gene transcription. Am J Physiol Gastrointest Liver
Physiol. 295:G977–G986. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Wallace JL, Cucala M, Mugridge K and
Parente L: Secretagogue-specific effects of interleukin-1 on
gastric acid secretion. Am J Physiol. 261:G559–G564.
1991.PubMed/NCBI
|
|
110
|
Ham IH, Lee D and Hur H: Role of
Cancer-associated fibroblast in gastric cancer progression and
resistance to treatments. J Oncol. 2019:62707842019. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Howlett M, Menheniott TR, Judd LM and
Giraud AS: Cytokine signalling via gp130 in gastric cancer. Biochim
Biophys Acta. 1793:1623–1633. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Iyer SS and Cheng G: Role of interleukin
10 transcriptional regulation in inflammation and autoimmune
disease. Crit Rev Immunol. 32:23–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Qu X, Tang Y and Hua S: Immunological
approaches towards cancer and inflammation: A cross talk. Front
Immunol. 9:5632018. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Gao L, Weck MN, Michel A, Pawlita M and
Brenner H: Association between chronic atrophic gastritis and serum
antibodies to 15 Helicobacter pylori proteins measured by multiplex
serology. Cancer Res. 69:2973–2980. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Sugai H, Kono K, Takahashi A, Ichihara F,
Kawaida H, Fujii H and Matsumoto Y: Characteristic alteration of
monocytes with increased intracellular IL-10 and IL-12 in patients
with advanced-stage gastric cancer. J Surg Res. 116:277–287. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhang H, Li R, Cao Y, Gu Y, Lin C, Liu X,
Lv K, He X, Fang H, Jin K, et al: Poor clinical outcomes and
immunoevasive contexture in intratumoral IL-10-Producing
macrophages enriched gastric cancer patients. Ann Surg.
275:e626–e635. 2022. View Article : Google Scholar
|
|
117
|
Park HS, Kwon WS, Park S, Jo E, Lim SJ,
Lee CK, Lee JB, Jung M, Kim HS, Beom SH, et al: Comprehensive
immune profiling and immune-monitoring using body fluid of patients
with metastatic gastric cancer. J Immunother Cancer. 7:2682019.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Yarmohammadi R, Najafi K, Noroozbeygi M,
Didehvar K, Rastin A, Ataei F, Atashzar MR and Shushtari SS: The
Role of IL-6, IL-10 and CRP in gastrointestinal cancers. Cell Biol
Int. 49:1061–1078. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Nguyen TLM, Khurana SS, Sagartz JE, Mills
JC and DiPaolo R: EBI3 (IL-27/IL-35) regulates the progression from
atrophic gastritis to gastric cancer by Regulating IL-17 production
in the gastric mucosa. Gastroenterology. 146(Suppl 1): S64–S65.
2014. View Article : Google Scholar
|
|
120
|
Bockerstett KA, Nguyen TLM, Wong CF, Ford
EL and DiPaolo RJ: IL-27 Regulates gastric metaplasia through
effects on both immune and epithelial cells. Gastroenterology.
152(Suppl 1): S55–S56. 2017. View Article : Google Scholar
|
|
121
|
Bockerstett K, Petersen C, Ford E,
Goldenring JR and DiPaolo R: IL-17A promotes the progression from
gastritis to gastric cancer. Gastroenterology. 150(Suppl 1): S110.
2016. View Article : Google Scholar
|
|
122
|
Bockerstett KA, Petersen C, Noto CN, Kuehm
L, Wong CF, Ford EL, Mills J, Goldenring JR and DiPaolo RJ:
Interleukin-27-producing immune cells in the gastric mucosa protect
the stomach from inflammation-induced atrophy and metaplasia.
Gastroenterology. 156(Suppl 1): S186. 2019. View Article : Google Scholar
|
|
123
|
Gu C, Wu L and Li X: IL-17 family:
Cytokines, receptors and signaling. Cytokine. 64:477–485. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Zhao J, Chen X, Herjan T and Li X: The
role of interleukin-17 in tumor development and progression. J Exp
Med. 217:e201902972020. View Article : Google Scholar :
|
|
125
|
Kabir S: The role of interleukin-17 in the
Helicobacter pylori induced infection and immunity. Helicobacter.
16:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Meng XY, Zhou CH, Ma J, Jiang C and Ji P:
Expression of interleukin-17 and its clinical significance in
gastric cancer patients. Med Oncol. 29:3024–3028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Brackman LC, Jung MS, Green EH, Joshi N,
Revetta FL, McClain MS, Markham NO, Piazuelo MB and Scott Algood
HM: IL-17 signaling protects against Helicobacter pylori-induced
gastric cancer. Gut microbes. 16:24304212024. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Tangye SG and Puel A: The Th17/IL-17 Axis
and host defense against fungal infections. J Allergy Clin Immunol
Pract. 11:1624–1634. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Kabil AK, Liu LT, Xu C, Nayyar N, González
L, Chopra S, Brassard J, Beaulieu MJ, Li Y, Damji A, et al:
Microbial dysbiosis sculpts a systemic ILC3/IL-17 axis governing
lung inflammatory responses and central hematopoiesis. Mucosal
Immunol. 18:1139–1158. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Zhang J and Shen M: The Role of IL-17 in
systemic autoinflammatory diseases: Mechanisms and therapeutic
perspectives. Clin Rev Allergy Immunol. 68:272025. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhong F, Cui D, Tao H, Du H and Xing C:
IL-17A-producing T cells and associated cytokines are involved in
the progression of gastric cancer. Oncol Rep. 34:2365–2374. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Zhang J, Li S, Zhao Y, Ma P, Cao Y, Liu C,
Zhang X, Wang W, Chen L and Li Y: Cancer-associated fibroblasts
promote the migration and invasion of gastric cancer cells via
activating IL-17a/JAK2/STAT3 signaling. Ann Transl Med. 8:8772020.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Karabulut M, Usul Afsar C, Serimez M and
Karabulut S: Serum IL-17 levels can be diagnostic for gastric
cancer. J BUON. 24:1601–1609. 2019.PubMed/NCBI
|
|
134
|
Park H, Li Z, Yang XO, Chang SH, Nurieva
R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q and Dong C: A distinct
lineage of CD4 T cells regulates tissue inflammation by producing
interleukin 17. Nat Immunol. 6:1133–1141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Onishi RM and Gaffen SL: Interleukin-17
and its target genes: Mechanisms of interleukin-17 function in
disease. Immunology. 129:311–321. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Otani K, Watanabe T, Tanigawa T, Okazaki
H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N and
Arakawa T: Anti-inflammatory effects of IL-17A on Helicobacter
pylori-induced gastritis. Biochem Biophys Res Commun. 382:252–258.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Chong Y, Yu D, Lu Z and Nie F: Role and
research progress of spasmolytic polypeptide-expressing metaplasia
in gastric cancer (Review). Int J Oncol. 64:332024. View Article : Google Scholar :
|
|
138
|
O'Keefe RN, Carli ALE, Baloyan D, Chisanga
D, Shi W, Afshar-Sterle S, Eissmann MF, Poh AR, Pal B, Seillet C,
et al: A tuft cell-ILC2 signaling circuit provides therapeutic
targets to inhibit gastric metaplasia and tumor development. Nat
Commun. 14:68722023. View Article : Google Scholar
|
|
139
|
von Moltke J, Ji M, Liang HE and Locksley
RM: Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial
response circuit. Nature. 529:221–225. 2016. View Article : Google Scholar
|
|
140
|
Waugh DJ and Wilson C: The interleukin-8
pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Brat DJ, Bellail AC and Van Meir EG: The
role of interleukin-8 and its receptors in gliomagenesis and
tumoral angiogenesis. Neuro Oncol. 7:122–133. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
He R, Li X, Zhang S, Liu Y, Xue Q, Luo Y,
Yu B, Li X and Liu Z: Dexamethasone inhibits IL-8 via glycolysis
and mitochondria-related pathway to regulate inflammatory pain. BMC
Anesthesiol. 23:3172023. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Lee KE, Khoi PN, Xia Y, Park JS, Joo YE,
Kim KK, Choi SY and Jung YD: Helicobacter pylori and interleukin-8
in gastric cancer. World J Gastroenterol. 19:8192–8202. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Noto CN, Hoft SG, Bockerstett KA, Jackson
NM, Ford EL, Vest LS and DiPaolo RJ: IL13 acts directly on gastric
epithelial cells to promote metaplasia development during chronic
gastritis. Cell Mol Gastroenterol Hepatol. 13:623–642. 2022.
View Article : Google Scholar :
|
|
145
|
Zhao R, Cao G, Zhang B, Wei L, Zhang X,
Jin M, He B, Zhang B, He Z and Bie Q: TNF+ regulatory T cells
regulate the stemness of gastric cancer cells through the
IL13/STAT3 pathway. Front Oncol. 13:11629382023. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Grünig G, Warnock M, Wakil AE, Venkayya R,
Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD,
Locksley RM and Corry DB: Requirement for IL-13 independently of
IL-4 in experimental asthma. Science. 282:2261–2263. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Seyfizadeh N, Seyfizadeh N, Gharibi T and
Babaloo Z: Interleukin-13 as an important cytokine: A review on its
roles in some human diseases. Acta Microbiol Immunol Hung.
62:341–378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Bockerstett K, Lewis SA, Wolf KJ, Noto CN,
Jackson NM, Ford EL, Ahn TH and DiPaolo RJ: Single-cell
transcriptional analyses of spasmolytic polypeptide-expressing
metaplasia arising from acute drug injury and chronic inflammation
in the stomach. Gut. 69:1027–1038. 2020. View Article : Google Scholar
|
|
149
|
Miska J, Lui JB, Toomer KH, Devarajan P,
Cai X, Houghton J, Lopez DM, Abreu MT, Wang G and Chen Z:
Initiation of inflammatory tumorigenesis by CTLA4 insufficiency due
to type 2 cytokines. J Exp Med. 215:841–858. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Dahl CA, Schall RP, He HL and Cairns JS:
Identification of a novel gene expressed in activated natural
killer cells and T cells. J Immunol. 148:597–603. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Meng D, Dong H, Wang C, Zang R and Wang J:
Role of interleukin-32 in cancer progression (review). Oncol Lett.
27:542024. View Article : Google Scholar
|
|
152
|
Han S and Yang Y: Interleukin-32: Frenemy
in cancer? BMB Rep. 52:165–174. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Fung KY, Nguyen PM and Putoczki TL:
Emerging roles for Interleukin-18 in the gastrointestinal tumor
microenvironment. Adv Exp Med Biol. 1240:59–72. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Khawar MB, Abbasi MH and Sheikh N: IL-32:
A novel pluripotent inflammatory interleukin, towards gastric
inflammation, gastric cancer, and chronic rhino sinusitis.
Mediators Inflamm. 2016:84137682016. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Bagheri V, Memar B, Momtazi AA, Sahebkar
A, Gholamin M and Abbaszadegan MR: Cytokine networks and their
association with Helicobacter pylori infection in gastric
carcinoma. J Cell Physiol. 233:2791–2803. 2018. View Article : Google Scholar
|
|
156
|
Li ML, Hong XX, Zhang WJ, Liang YZ, Cai
TT, Xu YF, Pan HF, Kang JY, Guo SJ and Li HW: Helicobacter pylori
plays a key role in gastric adenocarcinoma induced by spasmolytic
polypeptide-expressing metaplasia. World J Clin Cases.
11:3714–3724. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Kuo HY, Chang WL, Yeh YC, Cheng HC, Tsai
YC, Wu CT, Lin SH, Yang HB, Lu CC and Sheu BS: Spasmolytic
polypeptide-expressing metaplasia associated with higher
expressions of miR-21, 155, and 223 can be regressed by
Helicobacter pylori eradication in the gastric cancer familial
relatives. Helicobacter. 24:e125782019. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Yamaoka Y, Kodama T, Kita M, Imanishi J,
Kashima K and Graham DY: Relation between clinical presentation,
Helicobacter pylori density, interleukin 1beta and 8 production,
and cagA status. Gut. 45:804–811. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
El-Omar EM, Carrington M, Chow WH, McColl
KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N,
et al: Interleukin-1 polymorphisms associated with increased risk
of gastric cancer. Nature. 404:398–402. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Jackson CB, Judd LM, Menheniott TR,
Kronborg I, Dow C, Yeomans ND, Boussioutas A, Robb L and Giraud AS:
Augmented gp130-mediated cytokine signalling accompanies human
gastric cancer progression. J Pathol. 213:140–151. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Yamaoka Y, Kita M, Kodama T, Sawai N and
Imanishi J: Helicobacter pylori cagA gene and expression of
cytokine messenger RNA in gastric mucosa. Gastroenterology.
110:1744–1752. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Balkwill F: Tumour necrosis factor and
cancer. Nat Rev Cancer. 9:361–371. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Adamsson J, Ottsjö LS, Lundin SB,
Svennerholm AM and Raghavan S: Gastric expression of IL-17A and
IFNγ in Helicobacter pylori infected individuals is related to
symptoms. Cytokine. 99:30–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Wang F, Meng W, Wang B and Qiao L:
Helicobacter pylori-induced gastric inflammation and gastric
cancer. Cancer Lett. 345:196–202. 2014. View Article : Google Scholar
|
|
165
|
Goldenring JR, Ray GS, Coffey RJ, Meunier
PC, Haley PJ, Barnes TB and Car BD: Reversible drug-induced oxyntic
atrophy in rats. Gastroenterology. 118:1080–1093. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Nam KT, Lee HJ, Sousa JF, Weis VG, O'Neal
RL, Finke PE, Romero-Gallo J, Shi G, Mills JC, Peek RM Jr, et al:
Mature chief cells are cryptic progenitors for metaplasia in the
stomach. Gastroenterology. 139:2028–2037.e9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Weis VG, Sousa JF, LaFleur BJ, Nam KT,
Weis JA, Finke PE, Ameen NA, Fox JG and Goldenring JR:
Heterogeneity in mouse spasmolytic polypeptide-expressing
metaplasia lineages identifies markers of metaplastic progression.
Gut. 62:1270–1279. 2013. View Article : Google Scholar
|
|
168
|
Nomura S, Yamaguchi H, Ogawa M, Wang TC,
Lee JR and Goldenring JR: Alterations in gastric mucosal lineages
induced by acute oxyntic atrophy in wild-type and gastrin-deficient
mice. Am J Physiol Gastrointest Liver Physiol. 288:G362–G375. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Cardoso CM, Custódio JB, Almeida LM and
Moreno AJ: Mechanisms of the deleterious effects of tamoxifen on
mitochondrial respiration rate and phosphorylation efficiency.
Toxicol Appl Pharmacol. 176:145–152. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Huh WJ, Khurana SS, Geahlen JH, Kohli K,
Waller RA and Mills JC: Tamoxifen induces rapid, reversible
atrophy, and metaplasia in mouse stomach. Gastroenterology.
142:21–24.e27. 2012. View Article : Google Scholar
|
|
171
|
Kudo-Saito C, Imazeki H, Nagashima K,
Shoji H, Tsugaru K, Takahashi N, Kawakami T, Amanuma Y, Wakatsuki
T, Okano N, et al: IL33-ST2 axis is a predictive biomarker for
anti-PD1 therapeutic efficacy in advanced gastric cancer. J Transl
Med. 23:11252025. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Leidner R, Conlon K, McNeel DG,
Wang-Gillam A, Gupta S, Wesolowski R, Chaudhari M, Hassounah N, Lee
JB, Ho Lee L, et al: First-in-human phase I/Ib study of NIZ985, a
recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and
in combination with spartalizumab in patients with advanced and
metastatic solid tumors. J Immunother Cancer. 11:e0077252023.
View Article : Google Scholar
|
|
173
|
Lordick F, Thuss-Patience P, Bitzer M,
Maurus D, Sahin U and Türeci Ö: Immunological effects and activity
of multiple doses of zolbetuximab in combination with zoledronic
acid and interleukin-2 in a phase 1 study in patients with advanced
gastric and gastroesophageal junction cancer. J Cancer Res Clin
Oncol. 149:5937–5950. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Gooderham M, Ameen M, Hong HC, Katoh N,
Langley RG, Peris K, Reich K, Silvestre JF, Simpson E, Werfel T, et
al: Efficacy of up to 4 years of tralokinumab in adults with
moderate-to-severe atopic dermatitis. J Eur Acad Dermatol Venereol.
Nov 11–2025. View Article : Google Scholar : Epub ahead of
print.
|
|
175
|
Song EJ, Ehst B, Glick B, Lewitt GM, Rich
P, Ezra N, Bagel J, Anschutz T, Bialik B, Duan C, et al: Efficacy
and safety of risankizumab in genital or scalp psoriasis in the
UnlIMMited phase 4 randomized clinical trial at week 16. Dermatol
Ther (Heidelb). Oct 25–2025. View Article : Google Scholar : Epub ahead of
print.
|
|
176
|
Yu S, Yang M, Lim KM, Cho Y, Kim H, Lee K,
Jeong SH, Coffey RJ, Goldenring JR and Nam KT: Expression of LRIG1,
a negative regulator of EGFR, is dynamically altered during
different stages of gastric carcinogenesis. Am J Pathol.
188:2912–2923. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Dickerson LK, Carter JA, Kohli K and
Pillarisetty VG: Emerging interleukin targets in the tumour
microenvironment: Implications for the treatment of
gastrointestinal tumours. Gut. 72:1592–1606. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Mohamed AH, Ahmed AT, Al Abdulmonem W,
Bokov DO, Shafie A, Al-Hetty HRAK, Hsu CY, Alissa M, Nazir S,
Jamali MC and Mudhafar M: Interleukin-6 serves as a critical factor
in various cancer progression and therapy. Med Oncol. 41:1822024.
View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Tanigawa K and Redmond WL: Current
landscape and future prospects of interleukin-2 receptor (IL-2R)
agonists in cancer immunotherapy. Oncoimmunology. 14:24526542025.
View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Dong C, Tan D, Sun H, Li Z, Zhang L, Zheng
Y, Liu S, Zhang Y and He Q: Interleukin-12 delivery strategies and
advances in tumor immunotherapy. Curr Issues Mol Biol.
46:11548–11579. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Xu Y, Sun X and Tong Y: Interleukin-12 in
multimodal tumor therapies for induction of anti-tumor immunity.
Discov Oncol. 15:1702024. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Lee HM, Lee HJ and Chang JE: Inflammatory
cytokine: An attractive target for cancer treatment. Biomedicines.
10:21162022. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K and
Dai Z: Targeting cytokine and chemokine signaling pathways for
cancer therapy. Signal Transduct Target Ther. 9:1762024. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Holder PG, Lim SA, Huang CS, Sharma P,
Dagdas YS, Bulutoglu B and Sockolosky JT: Engineering interferons
and interleukins for cancer immunotherapy. Adv Drug Deliv Rev.
182:1141122022. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Tomasovic LM, Liu K, VanDyke D, Fabilane
CS and Spangler JB: Molecular engineering of interleukin-2 for
enhanced therapeutic activity in autoimmune diseases. BioDrugs.
38:227–248. 2024. View Article : Google Scholar :
|
|
186
|
Jeong H, Lee B, Kim KH, Cho SY, Cho Y,
Park J, Lee Y, Oh Y, Hwang BR, Jang AR, et al: WFDC2 Promotes
spasmolytic Polypeptide-Expressing metaplasia through the
Up-Regulation of IL33 in response to injury. Gastroenterology.
161:953–967.e15. 2021. View Article : Google Scholar
|
